[
    [
        {
            "time": "",
            "original_text": "医药行业疫苗子行业跟踪点评：国药灭活新冠疫苗附条件批准上市",
            "features": {
                "keywords": [
                    "医药",
                    "疫苗",
                    "国药",
                    "灭活",
                    "新冠",
                    "附条件",
                    "批准",
                    "上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业疫苗子行业跟踪点评：国药灭活新冠疫苗附条件批准上市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：新冠疫苗目前处于临床试验阶段，产品暂未上市",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新冠",
                    "疫苗",
                    "临床试验",
                    "产品",
                    "暂未上市"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物：新冠疫苗目前处于临床试验阶段，产品暂未上市",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【医药】新冠疫苗附条件上市，行业确定性逐步明晰——医药行业周报——中性",
            "features": {
                "keywords": [
                    "医药",
                    "新冠",
                    "疫苗",
                    "附条件",
                    "上市",
                    "行业",
                    "确定性",
                    "逐步明晰"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】新冠疫苗附条件上市，行业确定性逐步明晰——医药行业周报——中性",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]